Home/Filings/4/0001209191-17-044191
4//SEC Filing

Kite Pharma, Inc. 4

Accession 0001209191-17-044191

CIK 0001510580operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:15 PM ET

Size

11.3 KB

Accession

0001209191-17-044191

Insider Transaction Report

Form 4
Period: 2017-07-03
Wiezorek Jeffrey
VP Clinical Development
Transactions
  • Sale

    Common Stock

    2017-07-03$104.26/sh8,799$917,38422,272 total
  • Exercise/Conversion

    Common Stock

    2017-07-03$6.89/sh+10,000$68,90031,071 total
  • Sale

    Common Stock

    2017-07-03$104.76/sh1,201$125,81721,071 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-07-0310,00058,000 total
    Exercise: $6.89Exp: 2024-06-05Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.65 to $104.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.65 to $104.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]25% of the 175,000 shares originally subject to the stock option vested and became exercisable on May 5, 2015, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

Kite Pharma, Inc.

CIK 0001510580

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001510580

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:15 PM ET
Size
11.3 KB